🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06264492
Starting soon Observational

Delving Into Participation Trends of Scleroderma Clinical Trials

NCT06264492 · tracked via the Priya Life Science USA tracker
Sponsor
Power Life Sciences Inc.
Phase
Observational
Started
2025-03
Last updated
2024-02-28

Condition(s) studied

Scleroderma

Study summary

Typically, specific demographic subsets tend to exhibit greater engagement in medical research. Nonetheless, there is insufficient research elucidating the trial characteristics influencing the participation of these particular demographics.

The study will analyze data from diverse demographic viewpoints to uncover recurring trends that could provide valuable insights for future patients with scleroderma.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Patient has been diagnosed with scleroderma * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older Exclusion Criteria: * Patient is pregnant * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Power Life Sciences San Francisco California

More Power Life Sciences Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06264492 on ClinicalTrials.gov ↗ ← All trials in the USA